Dr Kirsten Peters, Head of Clinical Studies at Proteomics International (ASX: PIQ), was interviewed...
Endometriosis Diagnostic, PromarkerEndo – Channel 7 News Perth 4pm & 6pm
Proteomics International (ASX:PIQ) featured on Channel 7’s 4pm and 6pm news bulletins discussing PromarkerEndo, the Company’s prototype blood-test for diagnosing endometriosis.
Proteomics International has developed a prototype diagnostic blood test for endometriosis, PromarkerEndo. In a clinical validation study with over 900 participants, the test accurately identified up to 90% of patients, offering a breakthrough test for early screening of the disease.